Source:

Hoang
A
,
Chorath
K
,
Moreira
A
, et al
.
COVID-19 in 7780 pediatric patients: a systematic review [published online ahead of print June 9, 2020]
.
E Clinical Medicine, The Lancet
. doi:
https://doi.org/10.1016/j.eclinm.2020.1004332589-5370

Investigators from the University of Texas Health Sciences Center San Antonio and Texas Children’s Hospital, Houston, conducted a systematic review to characterize the demographics, presenting symptoms, laboratory findings, and outcomes in children diagnosed with COVID-19 and identify specific presenting symptoms and laboratory findings in those who developed multisystem inflammatory syndrome in children (MIS-C). The authors used a systematic process to identify relevant studies for inclusion. Data from studies of children and young adults from 0 to 21 years old with COVID-19, confirmed by PCR testing, were extracted. Patients were classified as developing MIS-C based on the CDC definition. Presenting symptoms and initial laboratory results were compared in children with MIS-C to those...

You do not currently have access to this content.